TREATMENT OF ADULT GROWTH HORMONE DEFICIENCY: WHO, WHY AND HOW? A REVIEW.

@article{Alexopoulou2010TREATMENTOA,
  title={TREATMENT OF ADULT GROWTH HORMONE DEFICIENCY: WHO, WHY AND HOW? A REVIEW.},
  author={Orsalia Alexopoulou and Roger Abs and Dominique Maiter},
  journal={Acta Clinica Belgica},
  year={2010},
  volume={65},
  pages={13 - 22}
}
Abstract Adult growth hormone deficiency (AGHD) is nowadays recognized as a distinct clinical entity and replacement therapy has become a standard practice. Reflecting on the accumulated evidence, questions nevertheless arise. Should all AGHD patients be treated? What dose of GH should be given and for how long? What are the real long-term benefits, in particular regarding life expectancy? If the diagnosis of severe GHD is firmly established and if there is no contra-indication (such as an… Expand
Myths and truths of growth hormone and testosterone therapy in heart failure
TLDR
To date, growth hormone and testosterone therapy have shown some positive benefits, albeit with some concerns over adverse effects, however, large randomized controlled trials are still needed to assess the long-term safety and efficacy. Expand
GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses.
TLDR
The published data lend support for the use of low GH dosing regimens in adult GHD and the range of doses defined as 'low dose' in the studies discussed here is in accordance with those recommended in current guidelines and encompasses the dose range recommended by product labels. Expand
Canadian endocrinologists' views on growth hormone replacement therapy in adult survivors of pediatric brain tumors following achievement of final height
TLDR
A study was undertaken to determine the views of Canadian endocrinologists on GHRT to treat growth hormone deficiency in sur vivors of pediatric brain tumors following achievement of final height, and to establish whether these views were in accord with Canadian provincial pharmaceutical policy regarding coverage for GHRT. Expand
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
TLDR
Somapacitan may provide an effective alternative to daily GH in AGHD and demonstrate superiority over placebo, and it improved other body composition parameters (including visceral fat and lean body mass) and IGF-I SDS. Expand
Provincial disparities of growth hormone coverage for young adult survivors of paediatric brain tumours across Canada.
TLDR
There are considerable out-of-pocket costs and variation in coverage provided by provincial public drug plans to fund GHRT for young adult survivors of PBTs with GHD, requiring the implementation of a national drug formulary to prevent undue financial hardship. Expand
Differences in the GH-IGF-I axis in children of different weight and fitness status.
TLDR
Fitness may contribute to the obesity related reduction of GH that may be involved with weight gain and insulin was related to fitness. Expand
Identification of novel GH-regulated genes in C2C12 cells.
  • E. Resmini, B. Morte, +6 authors S. Webb
  • Biology, Medicine
  • Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
  • 2011
TLDR
Modifications in the gene expression profile of the C2C12 cell line after rhGH exposure are shown, which revealed genes involved in skeletal and muscle system as well as cardiovascular system development and function. Expand
Toward a comprehensive differential diagnosis and clinical approach to fatigue in the elderly.
  • V. Morelli
  • Medicine
  • Clinics in geriatric medicine
  • 2011
This article provides primary care physicians with an encompassing approach to fatigue to help generate a comprehensive differential diagnosis. Two-thirds of patients with fatigue will have anExpand
Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 1
  • Michael Klentze
  • Medicine
  • Journal für Gynäkologische Endokrinologie/Schweiz
  • 2018
TLDR
Das bedeutet, dass die rhGH-Anwendung als ein hervorragendes Instrument in der Altersprävention geeignet sein könnte, ihre Bedeutung für die Präventionsmedizin, dem Alter und möglichen Interaktionen mit anderen Therapien richten sollte. Expand
...
1
2
...

References

SHOWING 1-10 OF 114 REFERENCES
Clinical aspects of growth hormone deficiency in adults.
TLDR
Since recombinant technology has solved the limitations in GH supply, policies concerning GH replacement therapy in man may now be reconsidered. Expand
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.
TLDR
GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD, and the risks associated with GH treatment are low. Expand
Management of growth hormone deficiency in adults.
  • A. Nilsson, J. Svensson, G. Johannsson
  • Medicine
  • Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
  • 2007
TLDR
The efficacy data on quality of life and well-being, long-term effects of GH replacement in adults and safety in terms of diabetes mellitus, pituitary tumour recurrence/regrowth and malignancy risk will be reviewed. Expand
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
TLDR
The results show that GH replacement in GHD adults results in marked alterations in body composition, fat distribution, and bone and mineral metabolism and reduces psychiatric symptoms. Expand
Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency.
TLDR
The results indicate that the sensitivity to GH in adult patients with GH deficiency is gender dependent and rhGH treatment continued to have an effect on bone metabolism and bone mass for up to 45 months of therapy. Expand
Growth Hormone Therapy for Adults: Not Ready for Prime Time?
  • W. Isley
  • Medicine
  • Annals of Internal Medicine
  • 2002
The availability of human growth hormone from recombinant DNA technology has led to a virtually limitless supply of this once scarce and rationed substance. Growth hormone therapy was once limited toExpand
Approach to the growth hormone-deficient child during transition to adulthood.
TLDR
The approach in determining which adolescents to retest, when and how to test for persistent GH deficiency, and which subjects to treat is discussed in the context of available clinical data. Expand
Adult growth hormone replacement: lessons learned and future direction.
TLDR
Establishing the benefit of GH replacement in the adult using weight-based dosing regimens made it ethically difficult to perform further randomized, placebo-controlled studies using an individually optimized GH dosing regimen. Expand
Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women.
TLDR
It is demonstrated that men and women with GHD display marked differences in their responsiveness to GH replacement therapy, and these differences should be taken into consideration when optimizing the treatment of GHD patients. Expand
Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism.
TLDR
The data are consistent with a GH-induced enhancement of peripheral deiodination of T4 to T3, and GH seems to play an important role, either directly or indirectly, in the regulation of peripheral T4 metabolism. Expand
...
1
2
3
4
5
...